NEW DRUGS - CLAVULANIC ACID - BETA-LACTAMASE INHIBITOR

被引：0
|
作者：
KOCH, H [1 ]
CLUXTON, RJ [1 ]
FYE, D [1 ]
机构：
[1] UNIV CINCINNATI,MED CTR,COLL PHARM,CINCINNATI,OH 45267
来源：
PHARMACY INTERNATIONAL | 1981年 / 2卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [41] DETERMINANTS OF THE ACTIVITY OF BETA-LACTAMASE INHIBITOR COMBINATIONS
    LIVERMORE, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 : 9 - 21
  • [42] ACQUIRED-RESISTANCE OF NOCARDIA-BRASILIENSIS TO CLAVULANIC ACID RELATED TO A CHANGE IN BETA-LACTAMASE FOLLOWING THERAPY WITH AMOXICILLIN-CLAVULANIC ACID
    STEINGRUBE, VA
    WALLACE, RJ
    BROWN, BA
    PANG, YJ
    ZELUFF, B
    STEELE, LC
    ZHANG, YS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) : 524 - 528
  • [43] SYN-1012: A new beta-lactamase inhibitor of penem skeleton
    Phillips, OA
    Czajkowski, DP
    Spevak, P
    Singh, MP
    HaneharaKunugita, C
    Hyodo, A
    Micetich, RG
    Maiti, SN
    JOURNAL OF ANTIBIOTICS, 1997, 50 (04): : 350 - 356
  • [44] INVITRO ACTIVITY OF BRL 25.000 (AMOXYCILLIN PLUS CLAVULANIC ACID) AGAINST ENTEROBACTERIACEAE BETA-LACTAMASE PRODUCERS
    ROY, C
    SEGURA, C
    TIRADO, M
    FUSTER, C
    FOZ, A
    MEDICINA CLINICA, 1982, 78 (05): : 189 - 195
  • [45] ACTIVITY OF CEFAZOLIN AND 2 BETA-LACTAMASE INHIBITORS, CLAVULANIC ACID AND SULBACTAM, AGAINST BACTEROIDES-FRAGILIS
    FEKETE, T
    MCGOWEN, J
    CUNDY, KR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) : 321 - 322
  • [46] Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations
    Stephanie Ho
    Lynn Nguyen
    Trang Trinh
    Conan MacDougall
    Current Infectious Disease Reports, 2019, 21
  • [47] PROTECTION OF PIPERACILLIN AND TICARCILLIN FROM BETA-LACTAMASE HYDROLYSIS BY TAZOBACTAM (YTR-830) AND CLAVULANIC ACID
    DIVER, JM
    THORNBER, D
    WISE, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (01) : 89 - 92
  • [48] Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations
    Ho, Stephanie
    Lynn Nguyen
    Trang Trinh
    MacDougall, Conan
    CURRENT INFECTIOUS DISEASE REPORTS, 2019, 21 (10)
  • [49] PIPERACILLIN/TAZOBACTAM - A NEW BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATION - COMMENT
    WANG, F
    SCHWENK, MH
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (10) : 1051 - 1052
  • [50] PIPERACILLIN TAZOBACTAM - A NEW BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATION - PREFACE
    FINCH, RG
    GREENWOOD, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 : R3 - R3
12345